
Sun Pharma to Acquire Checkpoint Therapeutics for $355 Million, Boosting Oncology Portfolio
Sun Pharma, India’s largest drug manufacturer by revenue, has announced the acquisition of Checkpoint Therapeutics Inc., a US-based biopharmaceutical company listed on Nasdaq.